Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8239606 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 10 Pages |
Abstract
Accurate pretherapeutic staging predicts the risk of subclinical nodal disease and should be used to select the appropriate radiotherapeutic PTV. Careful selection of the PTV can be used to maximize the therapeutic window in multimodal therapy for AEG.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Iris M.B.B.S., Susanne M.D., Thomas M.D., Rolf M.D., Werner M.D., Thomas B. M.D.,